← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 4, 2014Last known activity
Aug 1, 2024
Timeline
2000s
- Jun 1, 2004
Relmada Therapeutics, Inc.— Founded
2010s
- Dec 1, 2013
Medeor Therapeutics, Inc.— Acquired
Drugs by trial phase (8 distinct, 17 trials)
Phase 3 (1 own, 2 via acquisition)
Phase 2 (2 own, 3 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (16)
- NCT06009003Study directorN/A—
- NCT06009003Lead sponsorN/A—
- NCT06663137Lead sponsorPhase 2Aug 1, 2024
- NCT06011577Lead sponsorPhase 3Aug 17, 2023
- NCT06011577Study directorPhase 3Aug 17, 2023
- NCT05081167Study directorPhase 3Jun 2, 2021
- NCT05081167Lead sponsorPhase 3Jun 2, 2021
- NCT04855760Study directorPhase 3Apr 1, 2021
- NCT04855760Lead sponsorPhase 3Apr 1, 2021
- NCT04855747Study directorPhase 3Mar 30, 2021
- NCT04855747Lead sponsorPhase 3Mar 30, 2021
- NCT04688164Study directorPhase 3Dec 4, 2020
- NCT04688164Lead sponsorPhase 3Dec 4, 2020
- NCT03051256Lead sponsorPhase 2Jul 1, 2017
- NCT03638869Lead sponsorPhase 1Aug 31, 2015
Details
- Founded
- Coral Gables, FL, US Jun 1, 2004
- Last known activity
- Aug 1, 2024
Notes
changed founded location from Blue Bell, PA